Investor Presentaiton
US Business
Update on US FDA inspections
Facility
Capability
Last inspection Status post last inspection
Indore
Formulations
July 2022
St. Louis (US)
Formulations
November 2022
Received 1 observation. The Company has already submitted a detailed
response to the US FDA on the corrective and preventive actions it is taking
to address them.
Received 3 new observations. The Company is preparing the response for
USFDA.
Bioequivalence
Taloja (India)
April 2022
Successfully closed inspection without any observations
Centre
Baddi (India)
Formulations
February 2020
Inspection is closed. EIR# received in March 2020
Daman (India)
Formulations
August 2019
Inspection is closed. EIR# received in October 2019
California (US)
APIs
Ankleshwar (India)
APIs
Mandva (India)
APIs
August 2018
December 2016
September 2015
Inspection is closed. EIR# received in October 2018
Inspection is closed. EIR# received in March 2017
Inspection is closed. EIR# received in March 2016
#EIR - Establishment Inspection Report
ALKEMView entire presentation